Phase I trial of multiple ascending doses of NKTR 181 in healthy subjects.

Trial Profile

Phase I trial of multiple ascending doses of NKTR 181 in healthy subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 27 Feb 2012

At a glance

  • Drugs NKTR 181 (Primary)
  • Indications Pain
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 27 Feb 2012 Results published in a Nektar Therapeutics media release.
    • 14 Dec 2011 Full results have been accepted for presentation at the 2012 American Academy of Pain Medicine's 28th Annual Meeting, according to a Nektar Therapeutics media release.
    • 14 Dec 2011 Status changed from recruiting to completed, according to a Nektar Therapeutics media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top